{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:31:53Z","timestamp":1793035913055,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":869,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","award":["BFU2015-64405-R, SAF2016-77830-R, AARFD-17-503612, SAF2017-84117-R, RTI2018-094204-B-I00 and RTI2018-098830-B-I00"],"award-info":[{"award-number":["BFU2015-64405-R, SAF2016-77830-R, AARFD-17-503612, SAF2017-84117-R, RTI2018-094204-B-I00 and RTI2018-098830-B-I00"]}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13311-020-00986-4","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T17:02:35Z","timestamp":1611162155000},"page":"998-1016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Novel Interactions Involving the Mas Receptor Show Potential of the Renin\u2013Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia"],"prefix":"10.1016","volume":"18","author":[{"given":"Rafael","family":"Rivas-Santisteban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Lillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Rodr\u00edguez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Lu\u00eds","family":"Labandeira-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2549-4919","authenticated-orcid":false,"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-020-00986-4_bib1","doi-asserted-by":"crossref","unstructured":"Villela DC, Passos-Silva DG, Santos RAS. Alamandine: A new member of the angiotensin family. Vol. 23, Current Opinion in Nephrology and Hypertension. Curr Opin Nephrol Hypertens; 2014. p. 130\u20134.","DOI":"10.1097\/01.mnh.0000441052.44406.92"},{"issue":"4","key":"10.1007\/s13311-020-00986-4_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/SHK.0000000000000115","article-title":"Receptor mas protects mice against hypothermia and mortality induced by endotoxemia","volume":"41","author":"Souza","year":"2014","journal-title":"Shock."},{"key":"10.1007\/s13311-020-00986-4_bib3","doi-asserted-by":"crossref","unstructured":"Santos RAS, Simoes e Silva AC, Maric C, Silva DMR, Machado RP, de Buhr I, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A [Internet]. 2003;100(14):8258\u201363. Available from: http:\/\/www.pnas.org\/content\/100\/14\/8258.full","DOI":"10.1073\/pnas.1432869100"},{"key":"10.1007\/s13311-020-00986-4_bib4","doi-asserted-by":"crossref","unstructured":"Villela D, Leonhardt J, Patel N, Joseph J, Kirsch S, Hallberg A, et al. Angiotensin type 2 receptor (AT 2 R) and receptor Mas: a complex liaison. Clin Sci [Internet]. 2015;128(4):227\u201334. Available from: http:\/\/www.clinsci.org\/content\/128\/4\/227.abstract%5Cnhttp:\/\/clinsci.org\/lookup\/10.1042\/CS20130515","DOI":"10.1042\/CS20130515"},{"key":"10.1007\/s13311-020-00986-4_bib5","doi-asserted-by":"crossref","unstructured":"De Carvalho Santuchi M, Dutra MF, Vago JP, Lima KM, Galv\u00e3o I, De Souza-Neto FP, et al. Angiotensin-(1-7) and Alamandine Promote Anti-inflammatory Response in Macrophages in Vitro and in Vivo. Mediators Inflamm [Internet]. 2019 [cited 2020 Apr 29];2019(1):2401081. Available from: https:\/\/doi.org\/10.1155\/2019\/2401081","DOI":"10.1155\/2019\/2401081"},{"key":"10.1007\/s13311-020-00986-4_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/307315","article-title":"Angiotensin-Converting Enzyme 2: The First Decade","volume":"2012","author":"Clarke","year":"2012","journal-title":"Int J Hypertens [Internet]."},{"key":"10.1007\/s13311-020-00986-4_bib7","first-page":"94(7)","article-title":"Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus","volume":"29","author":"Wan","year":"2020","journal-title":"J Virol."},{"issue":"7807","key":"10.1007\/s13311-020-00986-4_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature."},{"key":"10.1007\/s13311-020-00986-4_bib9","doi-asserted-by":"crossref","unstructured":"Kuhn JH, Li W, Choe H, Farzan M. Angiotensin-converting enzyme 2: A functional receptor for SARS coronavirus [Internet]. Vol. 61, Cellular and Molecular Life Sciences. 2004 [cited 2020 May 26]. p. 2738\u201343. Available from: https:\/\/www.nature.com\/articles\/nature02145","DOI":"10.1007\/s00018-004-4242-5"},{"issue":"6965","key":"10.1007\/s13311-020-00986-4_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature."},{"key":"10.1007\/s13311-020-00986-4_bib11","doi-asserted-by":"crossref","unstructured":"Valenzuela R, Barroso-Chinea P, Villar-Cheda B, Joglar B, Mu\u00f1oz A, Lanciego JL, et al. Location of Prorenin Receptors in Primate Substantia Nigra: Effects on Dopaminergic Cell Death. J Neuropathol Exp Neurol [Internet]. 2010 Nov [cited 2019 Sep 1];69(11):1130\u201342. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20940627","DOI":"10.1097\/NEN.0b013e3181fa0308"},{"key":"10.1007\/s13311-020-00986-4_bib12","doi-asserted-by":"crossref","unstructured":"Jarrott B, Williams SJ. Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation. Neurochem Res [Internet]. 2016 Mar 16 [cited 2019 Oct 4];41(3):523\u201333. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26177578","DOI":"10.1007\/s11064-015-1661-7"},{"key":"10.1007\/s13311-020-00986-4_bib13","doi-asserted-by":"crossref","unstructured":"Perez-Lloret S, Otero-Losada M, Toblli JE, Capani F. Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease. Expert Opin Investig Drugs [Internet]. 2017 Oct 3 [cited 2019 Oct 15];26(10):1163\u201373. Available from: https:\/\/www.tandfonline.com\/full\/10.1080\/13543784.2017.1371133","DOI":"10.1080\/13543784.2017.1371133"},{"key":"10.1007\/s13311-020-00986-4_bib14","doi-asserted-by":"crossref","unstructured":"Villar-Cheda B, Dominguez-Meijide A, Valenzuela R, Granado N, Moratalla R, Labandeira-Garcia JL. Aging-related dysregulation of dopamine and angiotensin receptor interaction. Neurobiol Aging [Internet]. 2014 Jul [cited 2019 Sep 1];35(7):1726\u201338. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24529758","DOI":"10.1016\/j.neurobiolaging.2014.01.017"},{"key":"10.1007\/s13311-020-00986-4_bib15","doi-asserted-by":"crossref","unstructured":"Rabie MA, Abd El Fattah MA, Nassar NN, Abdallah DM, El-Abhar HS. Correlation between angiotensin 1\u20137-mediated Mas receptor expression with motor improvement, activated STAT3\/SOCS3 cascade, and suppressed HMGB-1\/RAGE\/NF-\u03baB signaling in 6-hydroxydopamine hemiparkinsonian rats. Biochem Pharmacol. 2020 Jan 1;171.","DOI":"10.1016\/j.bcp.2019.113681"},{"key":"10.1007\/s13311-020-00986-4_bib16","doi-asserted-by":"crossref","unstructured":"Mccarthy CA, Widdop RE, Deliyanti D, Wilkinson-Berka JL. Brain and retinal microglia in health and disease: An unrecognized target of the renin-angiotensin system. Vol. 40, Clinical and Experimental Pharmacology and Physiology. 2013. p. 571\u20139.","DOI":"10.1111\/1440-1681.12099"},{"key":"10.1007\/s13311-020-00986-4_bib17","doi-asserted-by":"crossref","unstructured":"Gironacci MM, Vicario A, Cerezo G, Silva MG. The depressor axis of the renin-angiotensin system and brain disorders: A translational approach. Vol. 132, Clinical Science. Portland Press Ltd; 2018. p. 1021\u201338.","DOI":"10.1042\/CS20180189"},{"key":"10.1007\/s13311-020-00986-4_bib18","doi-asserted-by":"crossref","unstructured":"Garrido-Gil P, Rodriguez-Perez AI, Fernandez-Rodriguez P, Lanciego JL, Labandeira-Garcia JL. Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells. Brain Struct Funct [Internet]. 2017 Aug 4 [cited 2019 Oct 8];222(6):2559\u201371. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28161727","DOI":"10.1007\/s00429-016-1357-z"},{"key":"10.1007\/s13311-020-00986-4_bib19","first-page":"12(4)","article-title":"Basal Ganglia Involvement and Altered Mental Status: A Unique Neurological Manifestation of Coronavirus Disease 2019","volume":"28","author":"Haddadi","year":"2020","journal-title":"Cureus."},{"key":"10.1007\/s13311-020-00986-4_bib20","first-page":"12(4)","article-title":"COVID-19 Pandemic: A Neurological Perspective","volume":"29","author":"Lahiri","year":"2020","journal-title":"Cureus."},{"key":"10.1007\/s13311-020-00986-4_bib21","doi-asserted-by":"crossref","unstructured":"Baig AM, Sanders EC. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19). J Med Virol [Internet]. 2020 Jun 3 [cited 2020 Jun 6]; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32492193","DOI":"10.1002\/jmv.26105"},{"key":"10.1007\/s13311-020-00986-4_bib22","first-page":"7(4)","article-title":"COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?","volume":"1","author":"Brun","year":"2020","journal-title":"Neurol Neuroimmunol neuroinflammation."},{"key":"10.1007\/s13311-020-00986-4_bib23","doi-asserted-by":"crossref","unstructured":"Dixon L, Varley J, Gontsarova A, Mallon D, Tona F, Muir D, et al. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol neuroinflammation [Internet]. 2020 Sep 3 [cited 2020 Jun 6];7(5). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32457227","DOI":"10.1212\/NXI.0000000000000789"},{"key":"10.1007\/s13311-020-00986-4_bib24","doi-asserted-by":"crossref","unstructured":"Rodriguez-Perez AI, Garrido-Gil P, Pedrosa MA, Garcia-Garrote M, Valenzuela R, Navarro G, et al. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra. Brain Behav Immun [Internet]. 2019 [cited 2020 Jun 6]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31863823\/","DOI":"10.1016\/j.bbi.2019.12.011"},{"key":"10.1007\/s13311-020-00986-4_bib25","doi-asserted-by":"crossref","unstructured":"Dominguez-Meijide A, Rodriguez-Perez AI, Diaz-Ruiz C, Guerra MJ, Labandeira-Garcia JL. Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures. Brain Behav Immun [Internet]. 2017 May [cited 2019 Oct 4];62:277\u201390. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28232171","DOI":"10.1016\/j.bbi.2017.02.013"},{"key":"10.1007\/s13311-020-00986-4_bib26","doi-asserted-by":"crossref","unstructured":"Labandeira-Garcia JL, Rodriguez-Pallares J, Dominguez-Meijide A, Valenzuela R, Villar-Cheda B, Rodr\u00edguez-Perez AI. Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease. Mov Disord [Internet]. 2013 Sep [cited 2019 Sep 1];28(10):1337\u201342. Available from: http:\/\/doi.wiley.com\/10.1002\/mds.25614","DOI":"10.1002\/mds.25614"},{"key":"10.1007\/s13311-020-00986-4_bib27","doi-asserted-by":"crossref","unstructured":"Costa-Besada MA, Valenzuela R, Garrido-Gil P, Villar-Cheda B, Parga JA, Lanciego JL, et al. Paracrine and Intracrine Angiotensin 1-7\/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans. Mol Neurobiol [Internet]. 2018 Jul 30 [cited 2019 Aug 30];55(7):5847\u201367. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29086247","DOI":"10.1007\/s12035-017-0805-y"},{"key":"10.1007\/s13311-020-00986-4_bib28","doi-asserted-by":"crossref","unstructured":"Jiang M, Huang W, Wang Z, Ren F, Luo L, Zhou J, et al. Anti-inflammatory effects of Ang-(1\u20137) via TLR4-mediated inhibition of the JNK\/FoxO1 pathway in lipopolysaccharide-stimulated RAW264.7 cells. Dev Comp Immunol. 2019 Mar 1;92:291\u20138.","DOI":"10.1016\/j.dci.2018.11.009"},{"key":"10.1007\/s13311-020-00986-4_bib29","doi-asserted-by":"crossref","unstructured":"Ferr\u00e9 S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, et al. Building a new conceptual framework for receptor heteromers. Nat Chem Biol [Internet]. 2009 Mar [cited 2020 May 11];5(3):131\u20134. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19219011","DOI":"10.1038\/nchembio0309-131"},{"key":"10.1007\/s13311-020-00986-4_bib30","doi-asserted-by":"crossref","unstructured":"Franco R, Mart\u00ednez-Pinilla E, Lanciego JLJLJL, Navarro G. Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization. Front Pharmacol [Internet]. 2016 Jan 31 [cited 2016 Apr 12];7(MAR):76. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27065866","DOI":"10.3389\/fphar.2016.00076"},{"key":"10.1007\/s13311-020-00986-4_bib31","doi-asserted-by":"crossref","unstructured":"Franco N, Franco R. Understanding the added value of g-protein-coupled receptor heteromers. Scientifica (Cairo) [Internet]. 2014;2014:362937. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4017843&tool=pmcentrez&rendertype=abstract","DOI":"10.1155\/2014\/362937"},{"key":"10.1007\/s13311-020-00986-4_bib32","doi-asserted-by":"crossref","unstructured":"Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, et al. Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal [Internet]. 2010 Jan [cited 2016 Feb 23];3(131):ra54. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3125674&tool=pmcentrez&rendertype=abstract","DOI":"10.1126\/scisignal.2000807"},{"key":"10.1007\/s13311-020-00986-4_bib33","doi-asserted-by":"crossref","unstructured":"Ciruela F, Casad\u00f3 V, Rodrigues R, Luj\u00e1n R, Burgue\u00f1o J, Canals M, et al. Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1-A2A Receptor Heteromers. J Neurosci [Internet]. 2006 Feb 15 [cited 2015 Mar 21];26(7):2080\u20137. Available from: http:\/\/www.jneurosci.org\/cgi\/10.1523\/JNEUROSCI.3574-05.2006","DOI":"10.1523\/JNEUROSCI.3574-05.2006"},{"issue":"21","key":"10.1007\/s13311-020-00986-4_bib34","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s00018-006-6216-2","article-title":"Heterodimeric adenosine receptors: A device to regulate neurotransmitter release","volume":"63","author":"Ciruela","year":"2006","journal-title":"Cell Mol Life Sci."},{"key":"10.1007\/s13311-020-00986-4_bib35","doi-asserted-by":"crossref","unstructured":"Crist\u00f3v\u00e3o-Ferreira S, Navarro G, Brugarolas M, P\u00e9rez-Capote K, Vaz SH, Fattorini G, et al. A1R-A2AR heteromers coupled to Gs and G i\/o proteins modulate GABA transport into astrocytes. Purinergic Signal [Internet]. 2013 Sep [cited 2015 Dec 14];9(3):433\u201349. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3757138&tool=pmcentrez&rendertype=abstract","DOI":"10.1007\/s11302-013-9364-5"},{"key":"10.1007\/s13311-020-00986-4_bib36","doi-asserted-by":"crossref","unstructured":"Navarro G, Cordom\u00ed A, Brugarolas M, Moreno E, Aguinaga D, P\u00e9rez-Benito L, et al. Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain. BMC Biol [Internet]. 2018;16:24(1):1\u201315. Available from: https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-018-0491-x","DOI":"10.1186\/s12915-018-0491-x"},{"key":"10.1007\/s13311-020-00986-4_bib37","doi-asserted-by":"crossref","unstructured":"Navarro G, Cordom\u00ed A, Zelman-Femiak M, Brugarolas M, Moreno E, Aguinaga D, et al. Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs. BMC Biol [Internet]. 2016 Jan 5 [cited 2016 Apr 8];14(1):26. Available from: http:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-016-0247-4","DOI":"10.1186\/s12915-016-0247-4"},{"key":"10.1007\/s13311-020-00986-4_bib38","doi-asserted-by":"crossref","unstructured":"Hinz S, Navarro G, Borroto-Escuela D, Seibt BF, Ammon C, Filippo E De, et al. Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors. Oncotarget [Internet]. 2018 Mar 2 [cited 2018 Apr 5];9(17):13593\u2013611. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29568380","DOI":"10.18632\/oncotarget.24423"},{"key":"10.1007\/s13311-020-00986-4_bib39","doi-asserted-by":"crossref","unstructured":"Porrello ER, Pfleger KDG, Seeber RM, Qian H, Oro C, Abogadie F, et al. Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles. Cell Signal [Internet]. 2011 Nov [cited 2019 Aug 30];23(11):1767\u201376. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21740964","DOI":"10.1016\/j.cellsig.2011.06.011"},{"key":"10.1007\/s13311-020-00986-4_bib40","doi-asserted-by":"crossref","unstructured":"Leonhardt J, Villela DC, Teichmann A, M\u00fcnter L-M, Mayer MC, Mardahl M, et al. Evidence for Heterodimerization and Functional Interaction of the Angiotensin Type 2 Receptor and the Receptor MASNovelty and Significance. Hypertension [Internet]. 2017 Jun [cited 2019 Aug 30];69(6):1128\u201335. Available from: http:\/\/hyper.ahajournals.org\/lookup\/10.1161\/HYPERTENSIONAHA.116.08814","DOI":"10.1161\/HYPERTENSIONAHA.116.08814"},{"key":"10.1007\/s13311-020-00986-4_bib41","doi-asserted-by":"crossref","unstructured":"Patel S, Hussain T. Dimerization of AT2 and Mas Receptors in Control of Blood Pressure. Curr Hypertens Rep [Internet]. 2018 May 1 [cited 2018 May 6];20(5):1\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29717388","DOI":"10.1007\/s11906-018-0845-3"},{"key":"10.1007\/s13311-020-00986-4_bib42","first-page":"17(1)","article-title":"Angiotensin AT1and AT2receptor heteromer expression in the hemilesioned rat model of Parkinson's disease that increases with levodopa-induced dyskinesia","volume":"29","author":"Rivas-Santisteban","year":"2020","journal-title":"J Neuroinflammation."},{"key":"10.1007\/s13311-020-00986-4_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2014.10.059","article-title":"2\u2032,3\u2032-cAMP, 3\u2032-AMP, 2\u2032-AMP and adenosine inhibit TNF-\u03b1 and CXCL10 production from activated primary murine microglia via A2A receptors","volume":"1594","author":"Newell","year":"2015","journal-title":"Brain Res."},{"key":"10.1007\/s13311-020-00986-4_bib44","doi-asserted-by":"crossref","unstructured":"Hradsky J, Mikhaylova M, Karpova A, Kreutz MR, Zuschratter W. Super-resolution microscopy of the neuronal calcium-binding proteins Calneuron-1 and Caldendrin. Methods Mol Biol [Internet]. 2013 [cited 2017 Jun 4];963:147\u201369. Available from: http:\/\/link.springer.com\/10.1007\/978-1-62703-230-8_10","DOI":"10.1007\/978-1-62703-230-8_10"},{"key":"10.1007\/s13311-020-00986-4_bib45","doi-asserted-by":"crossref","unstructured":"Reyes-Resina I, Navarro G, Aguinaga D, Canela EI, Schoeder CT, Za\u0142uski M, et al. Molecular and functional interaction between GPR18 and cannabinoid CB2G-protein-coupled receptors. Relevance in neurodegenerative diseases. Biochemical Pharmacology [Internet]. 2018 Jun [cited 2018 Jun 26];In the Press. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218302090","DOI":"10.1016\/j.bcp.2018.06.001"},{"key":"10.1007\/s13311-020-00986-4_bib46","doi-asserted-by":"crossref","unstructured":"Navarro G, Borroto-Escuela D, Angelats E, Etayo I, Reyes-Resina I, Pulido-Salgado M, et al. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia. Brain Behav Immun [Internet]. 2018 Aug [cited 2018 Feb 3];67:139\u201351. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159117304038","DOI":"10.1016\/j.bbi.2017.08.015"},{"key":"10.1007\/s13311-020-00986-4_bib47","doi-asserted-by":"crossref","unstructured":"Farr\u00e9 D, Mu\u00f1oz A, Moreno E, Reyes-Resina I, Canet-Pons J, Dopeso-Reyes IG, et al. Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia. Mol Neurobiol [Internet]. 2015 Oct 26 [cited 2014 Oct 29];52(3):1408\u201320. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25344317","DOI":"10.1007\/s12035-014-8936-x"},{"key":"10.1007\/s13311-020-00986-4_bib48","doi-asserted-by":"crossref","unstructured":"Pinna A, Bonaventura J, Farr\u00e9 D, S\u00e1nchez M, Simola N, Mallol J, et al. l-DOPA disrupts adenosine A2A\u2013cannabinoid CB1\u2013dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies. Exp Neurol [Internet]. 2014 Mar [cited 2015 Mar 17];253:180\u201391. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24412491","DOI":"10.1016\/j.expneurol.2013.12.021"},{"key":"10.1007\/s13311-020-00986-4_bib49","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz A, Garrido-Gil P, Dominguez-Meijide A, Labandeira-Garcia JL. Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1\u00df. Exp Neurol [Internet]. 2014 Nov [cited 2017 Aug 2];261:720\u201332. Available from: https:\/\/doi.org\/10.1016\/j.expneurol.2014.08.019","DOI":"10.1016\/j.expneurol.2014.08.019"},{"issue":"2","key":"10.1007\/s13311-020-00986-4_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol Dis."},{"issue":"1","key":"10.1007\/s13311-020-00986-4_bib51","first-page":"229","article-title":"Use-dependent structural events in recovery of function","volume":"73","author":"Schallert","year":"1997","journal-title":"Adv Neurol."},{"key":"10.1007\/s13311-020-00986-4_bib52","doi-asserted-by":"crossref","unstructured":"Kirik D, Winkler C, Bj\u00f6rklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci [Internet]. 2001 Apr 15 [cited 2016 Dec 7];21(8):2889\u201396. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11306640","DOI":"10.1523\/JNEUROSCI.21-08-02889.2001"},{"key":"10.1007\/s13311-020-00986-4_bib53","doi-asserted-by":"crossref","unstructured":"Lee CS, Cenci MA, Schulzer M, Bj\u00f6rklund A. Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain [Internet]. 2000 Jul [cited 2016 Dec 7];123 ( Pt 7:1365\u201379. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10869049","DOI":"10.1093\/brain\/123.7.1365"},{"key":"10.1007\/s13311-020-00986-4_bib54","doi-asserted-by":"crossref","unstructured":"Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci Nilsson MA. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci [Internet]. 2002 Jan [cited 2016 Dec 7];15(1):120\u201332. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11860512","DOI":"10.1046\/j.0953-816x.2001.01843.x"},{"key":"10.1007\/s13311-020-00986-4_bib55","doi-asserted-by":"crossref","unstructured":"Benito C, N\u00fa\u00f1ez E, Tol\u00f3n RM, Carrier EJ, R\u00e1bano A, Hillard CJ, et al. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci [Internet]. 2003 Dec 3 [cited 2016 Feb 18];23(35):11136\u201341. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14657172","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003"},{"key":"10.1007\/s13311-020-00986-4_bib56","doi-asserted-by":"crossref","unstructured":"De Filippis D, Steardo A, D'Amico A, Scuderi C, Cipriano M, Esposito G, et al. Differential Cannabinoid Receptor Expression during Reactive Gliosis: a Possible Implication for a Nonpsychotropic Neuroprotection. Sci World J [Internet]. 2009 Mar 31 [cited 2016 Dec 7];9:229\u201335. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19347234","DOI":"10.1100\/tsw.2009.31"},{"key":"10.1007\/s13311-020-00986-4_bib57","doi-asserted-by":"crossref","unstructured":"Ohlin KE, Sebastianutto I, Adkins CE, Lundblad C, Lockman PR, Cenci MA. Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease. Neuroimage [Internet]. 2012 May 15 [cited 2016 Dec 7];61(1):228\u201339. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053811912002510","DOI":"10.1016\/j.neuroimage.2012.02.066"},{"key":"10.1007\/s13311-020-00986-4_bib58","doi-asserted-by":"crossref","unstructured":"Navarro G, Hradsky J, Llu\u00eds C, Casad\u00f3 V, McCormick PJ, Kreutz MR, et al. NCS-1 associates with adenosine A(2A) receptors and modulates receptor function. Front Mol Neurosci [Internet]. 2012 Apr;5(April):53. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3328853&tool=pmcentrez&rendertype=abstract","DOI":"10.3389\/fnmol.2012.00053"},{"key":"10.1007\/s13311-020-00986-4_bib59","doi-asserted-by":"crossref","unstructured":"Chen T-W, Wardill TJ, Sun Y, Pulver SR, Renninger SL, Baohan A, et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature [Internet]. 2013 Jul 17 [cited 2017 Jun 4];499(7458):295\u2013300. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23868258","DOI":"10.1038\/nature12354"},{"key":"10.1007\/s13311-020-00986-4_bib60","doi-asserted-by":"crossref","unstructured":"Law AMK, Yin JXM, Castillo L, Young AIJ, Piggin C, Rogers S, et al. Andy's Algorithms: new automated digital image analysis pipelines for FIJI. Sci Rep [Internet]. 2017 Dec 16 [cited 2019 Aug 26];7(1):15717. Available from: http:\/\/www.nature.com\/articles\/s41598-017-15885-6","DOI":"10.1038\/s41598-017-15885-6"},{"key":"10.1007\/s13311-020-00986-4_bib61","doi-asserted-by":"crossref","unstructured":"Giles ME, Fernley RT, Nakamura Y, Moeller I, Aldred GP, Ferraro T, et al. Characterization of a specific antibody to the rat angiotensin II AT1 receptor. J Histochem Cytochem [Internet]. 1999 [cited 2020 Oct 25];47(4):507\u201315. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/10082752\/","DOI":"10.1177\/002215549904700409"},{"key":"10.1007\/s13311-020-00986-4_bib62","doi-asserted-by":"crossref","unstructured":"Valenzuela R, Costa-Besada MAMA, Iglesias-Gonzalez J, Perez-Costas E, Villar-Cheda B, Garrido-Gil P, et al. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration. Cell Death Dis [Internet]. 2016 Oct 20 [cited 2019 Sep 1];7(10):e2427. Available from: https:\/\/doi.org\/10.1038\/cddis.2016.327%5Cnhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27763643","DOI":"10.1038\/cddis.2016.327"},{"key":"10.1007\/s13311-020-00986-4_bib63","doi-asserted-by":"crossref","unstructured":"Carriba P, Navarro G, Ciruela F, Ferr\u00e9 S, Casad\u00f3 V, Agnati L, et al. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods [Internet]. 2008 Aug [cited 2015 Nov 22];5(8):727\u201333. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18587404","DOI":"10.1038\/nmeth.1229"},{"key":"10.1007\/s13311-020-00986-4_bib64","doi-asserted-by":"crossref","unstructured":"Franco R, Fern\u00e1ndez-Su\u00e1rez D. Alternatively activated microglia and macrophages in the central nervous system. Prog Neurobiol [Internet]. 2015 Jun 8 [cited 2015 Jun 14];131:65\u201386. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26067058","DOI":"10.1016\/j.pneurobio.2015.05.003"},{"key":"10.1007\/s13311-020-00986-4_bib65","doi-asserted-by":"crossref","unstructured":"Ferr\u00e9 S, Goldberg SR, Lluis C, Franco R. Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology [Internet]. 2009 Jan [cited 2017 Dec 27];56(SUPPL. 1):226\u201334. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18691604","DOI":"10.1016\/j.neuropharm.2008.06.076"},{"key":"10.1007\/s13311-020-00986-4_bib66","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Pinilla E, Rico AJ, Rivas-Santisteban R, Lillo J, Roda E, Navarro G, et al. Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates. Brain Struct Funct [Internet]. 2020 Sep 1 [cited 2020 Oct 28];225(7):2153\u201364. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32691218\/","DOI":"10.1007\/s00429-020-02116-4"},{"key":"10.1007\/s13311-020-00986-4_bib67","doi-asserted-by":"crossref","unstructured":"Tebano MT, Martire A, Popoli P. Adenosine A2A-cannabinoid CB1 receptor interaction: An integrative mechanism in striatal glutamatergic neurotransmission [Internet]. Vol. 1476, Brain Research. Brain Res; 2012 [cited 2020 Sep 24]. p. 108\u201318. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22565012\/","DOI":"10.1016\/j.brainres.2012.04.051"},{"key":"10.1007\/s13311-020-00986-4_bib68","doi-asserted-by":"crossref","unstructured":"Ferr\u00e9 S, Agnati LF, Ciruela F, Lluis C, Woods AS, Fuxe K, et al. Neurotransmitter receptor heteromers and their integrative role in \u201clocal modules\u201d: The striatal spine module. Brain Res Rev [Internet]. 2007 Aug [cited 2017 Dec 27];55(1):55\u201367. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17408563","DOI":"10.1016\/j.brainresrev.2007.01.007"},{"key":"10.1007\/s13311-020-00986-4_bib69","doi-asserted-by":"crossref","unstructured":"Ferr\u00e9 S, Ciruela F, Quiroz C, Luj\u00e1n R, Popoli P, Cunha RARA, et al. Adenosine receptor heteromers and their integrative role in striatal function. ScientificWorldJournal [Internet]. 2007 Jan 2 [cited 2016 Feb 15];7(SUPPL. 2):74\u201385. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17982579\/","DOI":"10.1100\/tsw.2007.211"},{"key":"10.1007\/s13311-020-00986-4_bib70","doi-asserted-by":"crossref","unstructured":"Franco R, Lluis C, Canela EI, Mallol J, Agnati L, Casad\u00f3 V, et al. Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins. J Neural Transm [Internet]. 2007 Jan 9 [cited 2018 Dec 30];114(1):93\u2013104. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17024327","DOI":"10.1007\/s00702-006-0566-7"},{"key":"10.1007\/s13311-020-00986-4_bib71","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Pinilla E, Rodr\u00edguez-P\u00e9rez AII, Navarro G, Aguinaga D, Moreno E, Lanciego JLL, et al. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum. Biochem Pharmacol [Internet]. 2015 Jul 15 [cited 2015 Dec 6];96(2):131\u201342. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521500252X","DOI":"10.1016\/j.bcp.2015.05.006"},{"key":"10.1007\/s13311-020-00986-4_bib72","doi-asserted-by":"crossref","unstructured":"Villar-Cheda B, Valenzuela R, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL. Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration. Neurobiol Aging [Internet]. 2012 Jan [cited 2019 Sep 1];33(1):204.e1-11. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458010003544","DOI":"10.1016\/j.neurobiolaging.2010.08.006"},{"key":"10.1007\/s13311-020-00986-4_bib73","doi-asserted-by":"crossref","unstructured":"Arnold AC, Gallagher PE, Diz DI. Brain renin-angiotensin system in the nexus of hypertension and aging. Vol. 36, Hypertension Research. Hypertens Res; 2013. p. 5\u201313.","DOI":"10.1038\/hr.2012.161"},{"key":"10.1007\/s13311-020-00986-4_bib74","unstructured":"Oertel WH. Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia. Arzneimittelforschung [Internet]. 1995 Mar [cited 2020 Jun 7];45(3A):386\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7763330"},{"key":"10.1007\/s13311-020-00986-4_bib75","doi-asserted-by":"crossref","unstructured":"Rocca W. Frequency, distribution, and risk factors for Alzheimer's disease. Nurs Clin North Am [Internet]. 1994 [cited 2020 Jun 7];29(1):101\u201311. Available from: https:\/\/europepmc.org\/abstract\/med\/8121814","DOI":"10.1016\/S0029-6465(22)02715-3"},{"key":"10.1007\/s13311-020-00986-4_bib76","doi-asserted-by":"crossref","unstructured":"Hornykiewicz O. The discovery of dopamine deficiency in the parkinsonian brain. J Neural Transm Suppl [Internet]. 2006;70:9\u201315. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17017502","DOI":"10.1007\/978-3-211-45295-0_3"},{"key":"10.1007\/s13311-020-00986-4_bib77","doi-asserted-by":"crossref","unstructured":"Tang D, Comish P, Kang R. The hallmarks of COVID-19 disease. PLoS Pathog [Internet]. 2020 [cited 2020 Jun 7];16(5):e1008536. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32442210","DOI":"10.1371\/journal.ppat.1008536"},{"key":"10.1007\/s13311-020-00986-4_bib78","doi-asserted-by":"crossref","unstructured":"Lyngs\u00f8 C, Erikstrup N, Hansen JL. Functional interactions between 7TM receptors in the Renin-Angiotensin System-Dimerization or crosstalk? Vol. 302, Molecular and Cellular Endocrinology. 2009. p. 203\u201312.","DOI":"10.1016\/j.mce.2008.09.018"},{"key":"10.1007\/s13311-020-00986-4_bib79","doi-asserted-by":"crossref","unstructured":"Ferr\u00e3o FM, Lara LS, Axelband F, Dias J, Carmona AK, Reis RI, et al. Exposure of luminal membranes of LLC-PK 1 cells to ANG II induces dimerization of AT 1 \/AT 2 receptors to activate SERCA and to promote Ca 2+ mobilization. Am J Physiol Physiol [Internet]. 2012 Apr 1 [cited 2019 Aug 30];302(7):F875\u201383. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22218590","DOI":"10.1152\/ajprenal.00381.2011"},{"key":"10.1007\/s13311-020-00986-4_bib80","doi-asserted-by":"crossref","unstructured":"Franco R, Aguinaga D, Jim\u00e9nez J, Lillo J, Mart\u00ednez-Pinilla E, Navarro G. Biased receptor functionality versus biased agonism in G-protein-coupled receptors. Biomol Concepts [Internet]. 2018 Dec 26 [cited 2019 Jul 26];9(1):143\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30864350","DOI":"10.1515\/bmc-2018-0013"},{"key":"10.1007\/s13311-020-00986-4_bib81","doi-asserted-by":"crossref","unstructured":"Franco R, Casad\u00f3 V, Cort\u00e9s A, Ferrada C, Mallol J, Woods A, et al. Basic concepts in G-protein-coupled receptor homo- and heterodimerization. ScientificWorldJournal. 2007;7(SUPPL. 2).","DOI":"10.1100\/tsw.2007.197"},{"key":"10.1007\/s13311-020-00986-4_bib82","doi-asserted-by":"crossref","unstructured":"Labandeira-Garcia J, Rodr\u00edguez-Perez A, Garrido-Gil P, Rodriguez-Pallares J, Lanciego J, Guerra M. Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration. Front Aging Neurosci [Internet]. 2017 May 3 [cited 2019 Oct 4];9(MAY):129. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28515690","DOI":"10.3389\/fnagi.2017.00129"},{"key":"10.1007\/s13311-020-00986-4_bib83","doi-asserted-by":"crossref","unstructured":"Rodriguez-Perez AI, Sucunza D, Pedrosa MA, Garrido-Gil P, Kulisevsky J, Lanciego JL, et al. Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death. Neurotherapeutics [Internet]. 2018 Oct 9 [cited 2019 Sep 1];15(4):1063\u201381. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29987762","DOI":"10.1007\/s13311-018-0646-z"},{"key":"10.1007\/s13311-020-00986-4_bib84","doi-asserted-by":"crossref","unstructured":"Rodriguez-Pallares J, Rey P, Parga JA, Mu\u00f1oz A, Guerra MJ, Labandeira-Garcia JL. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol Dis [Internet]. 2008 Jul [cited 2019 Oct 14];31(1):58\u201373. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108000533","DOI":"10.1016\/j.nbd.2008.03.003"},{"key":"10.1007\/s13311-020-00986-4_bib85","doi-asserted-by":"crossref","unstructured":"Saavedra JM. Beneficial effects of Angiotensin II receptor blockers in brain disorders. Vol. 125, Pharmacological Research. Academic Press; 2017. p. 91\u2013103.","DOI":"10.1016\/j.phrs.2017.06.017"},{"key":"10.1007\/s13311-020-00986-4_bib86","doi-asserted-by":"crossref","unstructured":"Pelisch N, Hosomi N, Ueno M, Masugata H, Murao K, Hitomi H, et al. Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system. Hypertens Res [Internet]. 2010 Feb 27 [cited 2020 Jul 6];33(2):161\u20134. Available from: www.nature.com\/hr","DOI":"10.1038\/hr.2009.200"},{"key":"10.1007\/s13311-020-00986-4_bib87","doi-asserted-by":"crossref","unstructured":"Foulquier S, Caolo V, Swennen G, Milanova I, Reinhold S, Recarti C, et al. The role of receptor MAS in microglia-driven retinal vascular development. Angiogenesis [Internet]. 2019 Nov 1 [cited 2020 Oct 23];22(4):481\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31240418\/","DOI":"10.1007\/s10456-019-09671-3"},{"issue":"6","key":"10.1007\/s13311-020-00986-4_bib88","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an Angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension."},{"key":"10.1007\/s13311-020-00986-4_bib89","doi-asserted-by":"crossref","unstructured":"Ferrada C, Moreno E, Casad\u00f3 V, Bongers G, Cort\u00e9s A, Mallol J, et al. Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br J Pharmacol [Internet]. 2009 May 8 [cited 2016 May 16];157(1):64\u201375. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19413572","DOI":"10.1111\/j.1476-5381.2009.00152.x"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00986-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00986-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00986-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:56:31Z","timestamp":1761807391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923011455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1878747923011455"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00986-4","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Interactions Involving the Mas Receptor Show Potential of the Renin\u2013Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00986-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}